Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma

Molecular Carcinogenesis

Volumn 48, Issue 3, 2009, Pages 196-201

  Yang, Zhi Hui ^a,b   Dai, Qiong ^a   Kong, Xiang Li ^c   Yang, Wen Li ^a   Zhang, Lin ^b  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Chinese population; ERCC1; NPC; SNPs; Susceptibility

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA MODIFICATION; ERCC1 GENE; FEMALE; GENDER; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; CASE CONTROL STUDY; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; NASOPHARYNX TUMOR; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

CASE-CONTROL STUDIES; CHINA; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 62349127863     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20468     Document Type: Article

References (30)

1. Chen DL, Huang TB. A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett 1997;117:17-22.
2. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:421-429.
3. Zheng X, Yan L, Nilsson B, et al. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol 1994;33:867-872.
4. Chen M, Kamat AM, Huang M, et al. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 2007;28:2160-2165.
5. Wilson MD, Ruttan CC, Koop BF, Glickman BW. ERC C1: A comparative genomic perspective. Environ Mol Mutagen 2001;38:209-215.
6. Sijbers AM, de Laat WL, Ariza RR, et al. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 1996;86:811-822.
7. Yu JJ, Lee KB, Mu C, et al. Comparison of two human ovarian carcinoma celllines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at 19007C>T of the ERCC1 gene. Int J Oncol 2000;16:555-560.
8. Chen P, Wiencke J, Aldape K, et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000;9:843-847.
9. Wang SL, Zhao H, Zhou B, et al. Polymorphisms in ERCC1 and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Leuk Res 2006;30:1341-1345.
10. Sturgis EM, Dahlstrom KR, Kristina R, Wei Q. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2002;128:1084-1088.
11. Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006;27:560-567.
12. John SW, Weitzner G, Rozen R, Scriver CR. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991;19:408.
13. Park DJ, Zhang W, Stoehlmacher J, et al. ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy. Clin Adv Hematol Oncol 2003;1:162-166.
14. Zhou W, Gurubhagavatula S, Liu G, et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 2004;10:4939-4943.
15. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-98.
16. Zhou W, Liu G, Park S. et al. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Epidemiol Biomarkers Prev 2005;14:491-496.
17. Wrensch M, Kelsey KT, Liu M, et al. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol 2005;7:495-507.
18. Matullo G, Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006;27:997-1007.
19. Yin J, Vogel U, Guo L, Ma Y, Wang H. Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population. Cancer Genet Cytogenet 2006;164:66-70.
20. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair gene and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-1530 [Erratum in: Cancer Epidemiol Biomarkers Prev 2003;12:1119].
21. van Duin M, de Wit J, Odijk H, et al. Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell 1986;44:913-923.
22. Bessho T, Sancar A, Thompson LH, Thelen MP. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem 1997;272:3833-3837.
23. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-608.
24. Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 2002;94:393-393.
25. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Voigt LF, Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2524-2530.
26. Vogel U, Laros I, Jacobsen NR, et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 2004;546:65-74.
27. Jo H, Kang S, Kim SI, et al. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study. Gynecol Obstet Invest 2007;64:84-88.
28. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: A paradigm for the promise and perils of individuals and population risk estimation? Mutat Res 1998;400:15-24.
29. Lee GY, Jang JS, Lee SY, et al. XPC polymorphisms and lung cancer risk. Int J Cancer 2005;115:807-813.
30. Friedberg EC, Bond JP, Burns DK, et al. Defective nucleotide excision repair in Xpc mutant mice and its association with cancer predisposition. Mutat Res 2000;459:99-108.